Company Overview - Entropy Technology Co., Ltd. was established in 2007, focusing on cognitive-driven intelligent space evolution as a global leader in AI services [2] - The company utilizes multi-modal BioCV (computer vision and biometrics) and cognitive space computing technology to create a comprehensive perception system, transitioning from static management to autonomous decision-making and evolution [2] Strategic Areas - The company is deeply engaged in four strategic areas: smart space, smart office, digital identity authentication, and smart business, providing AI-enabled integrated solutions [2] - The acquisition of a 55% stake in Longzhiyuan is expected to broaden the company's smart living business into outdoor areas, enhancing the product array in smart outdoor scenarios [2][3] Brain-Computer Interface (BCI) Development - The company is focusing on three core application scenarios for BCI technology: education, healthcare, and elderly care, leveraging AI-driven multi-modal data fusion technology [4] - A prototype for the BCI business is expected to be launched by March 2026, with a strategic partnership established with NeuroSky to enhance BCI technology integration [4] Financial Strategy - The company maintains a dual strategy of organic growth and external development, with the acquisition of Longzhiyuan being the first since its listing [5] - Future investments or acquisitions will be pursued to enhance company value [5] Customer Overlap and Market Expansion - The BCI business overlaps with existing clients primarily in the healthcare and education sectors, while also targeting new customer groups in consumer electronics, industry, and research [6] - The company has established a comprehensive ecosystem in multi-modal BioCV and AIoT, showcasing innovative BCI products at global events [7]

Group 1: Market Potential and Business Strategy - The brain-machine interface market is expected to grow significantly due to technological advancements, aging population, and policy support, with a focus on sustainable development [2] - The company acknowledges uncertainties regarding future revenue contributions from the brain-machine business and advises investors to consider associated risks [2] - The company aims to deepen the integration of AI and BioCV core technologies to drive product innovation and implement a multi-brand strategy [3] Group 2: Financial Performance - The company's non-GAAP net profit growth rate has significantly outpaced revenue growth, primarily due to increased export ratios leading to higher gross margins and reduced sales expenses [3] - 76% of the company's revenue comes from overseas markets, with notable growth in the Americas, Asia-Pacific, Middle East, and Europe [3] Group 3: Technological Capabilities - The company has developed core technologies in brainwave detection, eye movement analysis, multimodal small model analysis, audio analysis, and facial micro-expression analysis for human-computer interaction [3] - The company is progressing with the development of a brain-machine interface product, focusing on emotion analysis, with a prototype expected by March 2026 [3] Group 4: Acquisition and Expansion Plans - The company is advancing its acquisition of Longzhiyuan and will provide updates through official announcements [3] - The construction of the manufacturing facility in Atlanta, USA, is currently underway [3]

随着熵基科技研发实力持续加码，成果落地也逐步加速。2025年2月，熵基科技宣布其全新一代AI认知 空间平台——火星慧知平台正式面世，这一突破性的AI平台以熵基科技自主研发的BioCV多模态模型为 核心，不仅重新定义了智慧空间的边界，更通过全域智能生态，深度赋能智慧园区、智慧校园、智慧零 售等多元化场景，为企业运营决策、商业创新提供坚实的数据支撑。此外，火星慧知平台还与熵基明星 产品"万傲瑞达"强强联手，万傲瑞达专注于数据管理，火星慧知则聚焦于AI赋能，二者协同实现从数据 采集到智能决策的全链路支持，展现公司作为全球领先的智能空间进化服务商的"硬派"实力。 在市场拓展方面，熵基科技自2007年成立以来，始终坚定不移地走创新驱动和全球化路线，业务范围覆 盖全球100多个国家和地区。国内方面，熵基科技升级合作伙伴政策，推行"一省一策"本地化支持，建 立"发展联盟"共享技术资源，并启动百城巡展深化市场渗透。国外方面，公司以多模态BioCV为核心技 术基石，长期赋能多元业务场景，保持行业领先地位，凭借可覆盖超过100个国家和地区的营销服务网 络及本地化服务理念等优势，2024年，公司海外国家和地区销售收入为14.12亿 ...